grid-line

A:head bio

A biotechnology company specializing in the development of 3D tissue cultures from human stem cells through in vitro experiments. A:head bio aims to understand the brain's developmental processes to aid healthcare professionals in improving the quality of life for patients with central nervous system diseases, utilizing advanced techniques such as cell reprogramming, gene editing, and digital biology. The primary beneficiaries of A:head bio's innovations are researchers and healthcare providers focused on neurological disorders and brain health.
90
Volume
+115%
Growth
regular